Banerjee Munmun, Pandey Veda P
Department of Biochemistry, University of Lucknow, Lucknow 226007, India.
Institute of Food Processing and Technology, ONGC Centre for Advanced Studies, University of Lucknow, Lucknow 226007, India (Pesent Address).
Curr Protein Pept Sci. 2025;26(2):113-124. doi: 10.2174/0113892037329528240827180820.
Diet has emerged as a pivotal factor in the current time for diet-induced obesity (DIO). A diet overloaded with fats and carbohydrates and unhealthy dietary habits contribute to the development of DIO through several mechanisms. The prominent ones include the transition of normal gut microbiota to obese microbiota, under-expression of AMPK, and abnormally high levels of adipogenesis. DIO is the root of many diseases. The present review deals with various aspects of DIO and its target proteins that can be specifically used for its treatment. Also, the currently available treatment strategies have been explored. It was found that the expression of five proteins, namely, PPARγ, FTO, CDK4, 14-3-3 ζ protein, and Galectin-1, is upregulated in DIO. They can be used as potential targets for drug-designing studies. Thus, with these targets, the treatment strategy for DIO using natural bioactive compounds can be a safer alternative to medications and bariatric surgeries.
在当前因饮食诱导的肥胖(DIO)中,饮食已成为一个关键因素。富含脂肪和碳水化合物的饮食以及不健康的饮食习惯通过多种机制导致DIO的发展。其中突出的机制包括正常肠道微生物群向肥胖微生物群的转变、AMPK的表达不足以及异常高水平的脂肪生成。DIO是许多疾病的根源。本综述涉及DIO的各个方面及其可专门用于其治疗的靶蛋白。此外,还探讨了目前可用的治疗策略。研究发现,PPARγ、FTO、CDK4、14-3-3 ζ蛋白和半乳糖凝集素-1这五种蛋白在DIO中表达上调。它们可作为药物设计研究的潜在靶点。因此,有了这些靶点,使用天然生物活性化合物治疗DIO的策略可能是比药物和减肥手术更安全的选择。